i2O Therapeutics has filed a notice of an exempt offering of securities to raise $3,987,042.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, i2O Therapeutics is raising $3,987,042.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Kurt Graves played a key role…
